The therapeutic drugs for bronchial asthma are categorized into control and relieving drugs. 1. Control drugs: inhaled glucocorticosteroids, such as budesonide; long-acting β2 agonists, such as formoterol; leukotriene modulators, such as montelukast sodium, etc.; for long-term control of the condition. 2. Palliative drugs: short-acting β2 agonists, such as salbutamol; short-acting inhaled anticholinergic drugs, such as ipratropium bromide; short-acting theophyllines, such as aminophylline; systemic glucocorticosteroids, such as methylprednisolone; short-acting β2 agonists are preferred in acute attacks. Other drugs include sodium cromoglycate, anti-IgE antibody, anti-IL-5 antibody, etc. Patients are advised to visit the relevant departments of the hospital in time and use such drugs under the guidance of professional doctors and in accordance with the doctor’s instructions, in order to achieve the purpose of controlling the disease.